BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications. Clin Mol Hepatol 2018;24:230-77. [PMID: 29991196 DOI: 10.3350/cmh.2018.1005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng X, Bai Z, Wang T, Romeiro FG, Mancuso A, Philips CA, Wong YJ, Nery FG, Qi X. Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses. Adv Ther 2023. [PMID: 36697778 DOI: 10.1007/s12325-023-02430-3] [Reference Citation Analysis]
2 Gou X, Jia W, He C, Yuan X, Niu J, Xu J, Han N, Zhu Y, Wang W, Tie J. Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients. Eur Radiol 2022. [PMID: 36576548 DOI: 10.1007/s00330-022-09357-3] [Reference Citation Analysis]
3 Kim TH, Jung YK, Yim HJ, Baik JW, Yim SY, Lee YS, Seo YS, Kim JH, Yeon JE, Byun KS. Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis. Clin Mol Hepatol 2022;28:876-89. [PMID: 36117443 DOI: 10.3350/cmh.2022.0231] [Reference Citation Analysis]
4 Hentschel F, Schwarz T, Lüth S, Schreyer AG. Psoas muscle index predicts time to rehospitalization in liver cirrhosis: An observational study. Medicine (Baltimore) 2022;101:e30259. [PMID: 36086704 DOI: 10.1097/MD.0000000000030259] [Reference Citation Analysis]
5 Lee Y, Yoo KD, Baek SH, Kim YG, Kim HJ, Ryu JY, Paek JH, Suh SH, Oh SW, Lee J, Jhee JH, Suh J, Yang EM, Park YH, Kim YL, Choi M, Oh K, Kim S; on behalf of the Hyponatremia Guideline Development Group. Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia. Kidney Res Clin Pract 2022;41:S1-S30. [DOI: 10.23876/j.krcp.33.666] [Reference Citation Analysis]
6 Sobh M, Abdalbary M, Abdelsalam M, Mohamed AE. Renal Dysfunction in Patients with Liver Cirrhosis. Digestive Disease Interventions 2022;06:131-136. [DOI: 10.1055/s-0042-1746192] [Reference Citation Analysis]
7 Dong Y, Sun D, Wang Y, Du Q, Zhang Y, Han R, Teng M, Zhang T, Shi L, Zheng G, Dong Y, Wang T. Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure. BMC Infect Dis 2022;22:23. [PMID: 34983426 DOI: 10.1186/s12879-021-07018-2] [Reference Citation Analysis]
8 Praharaj DL, Anand AC. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis. J Clin Exp Hepatol 2022;12:575-94. [PMID: 35535075 DOI: 10.1016/j.jceh.2021.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Wang R, Chai L, Guo X. Diuretics in Cirrhotic Patients with Ascites. Pharmacotherapy for Liver Cirrhosis and Its Complications 2022. [DOI: 10.1007/978-981-19-2615-0_11] [Reference Citation Analysis]
10 Xia RQ, Yuan W, Ye MS, Wang J, Zeng XQ, Chen SY. Recurrent ascites in a man with liver cirrhosis: A case report. J Dig Dis 2021;22:727-30. [PMID: 34783434 DOI: 10.1111/1751-2980.13067] [Reference Citation Analysis]
11 Kim S, Lee Y, Cho N, Choi H, Kim K. A Systematic Review of Herbal Medicine in the Treatment of Cirrhotic Ascites. J Korean Med 2021;42:222-237. [DOI: 10.13048/jkm.21049] [Reference Citation Analysis]
12 Jeong S, Cho Y, Park SM, Kim W. Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy: A Systematic Review and Meta-analysis. J Clin Gastroenterol 2021;55:e77-86. [PMID: 33883516 DOI: 10.1097/MCG.0000000000001548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Oh JH, Goh MJ, Park Y, Kim J, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Paik YH. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events. Dig Dis Sci 2021;66:2816-25. [PMID: 32897445 DOI: 10.1007/s10620-020-06591-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Kim HS, Yi NJ, Kim JM, Joh JW, Lee KW, Suh KS. Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection. Ann Surg Treat Res 2021;101:85-92. [PMID: 34386457 DOI: 10.4174/astr.2021.101.2.85] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lee HA, Jung JY, Lee YS, Jung YK, Kim JH, An H, Yim HJ, Jeen YT, Yeon JE, Byun KS, Um SH, Seo YS. Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis. Gut Liver 2021;15:599-605. [PMID: 33293481 DOI: 10.5009/gnl20171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
16 Li C, Xiang W, Wu M, Zhang H, Cheng J, Yang T, Mai J, Chi X, Gao X, Ding Y, Niu J. A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects. Eur J Pharm Sci 2021;165:105923. [PMID: 34229078 DOI: 10.1016/j.ejps.2021.105923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kim JH, Park SW, Jung JH, Park DH, Bang CS, Park CH, Park JW, Park JG. Bedside risk-scoring model for predicting 6-week mortality in cirrhotic patients undergoing endoscopic band ligation for acute variceal bleeding. J Gastroenterol Hepatol 2021;36:1935-43. [PMID: 33538357 DOI: 10.1111/jgh.15426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yoon JH, Jun CH, Kim JH, Yoon EL, Kim BS, Song JE, Suk KT, Kim MY, Kang SH. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol. J Korean Med Sci 2021;36:e145. [PMID: 34060260 DOI: 10.3346/jkms.2021.36.e145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Jeon H, Kim JH, Lee SS, Kim HJ, Cha RR, Cho HC, Lee JM, Ha CY, Kim HJ, Kim TH, Jung WT, Lee OJ. Impact of acute kidney injury on survival in patients with chronic hepatitis C: a retrospective cohort study. BMC Infect Dis 2021;21:301. [PMID: 33765952 DOI: 10.1186/s12879-021-05991-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kykalos S, Machairas N, Ntikoudi E, Dorovinis P, Molmenti EP, Sotiropoulos GC. Inguinal Hernias in Cirrhotic Patients: From Diagnosis to Treatment. Surg Innov 2021;:1553350621995058. [PMID: 33599535 DOI: 10.1177/1553350621995058] [Reference Citation Analysis]
21 Kim TH, Seo YS, Kang SH, Kim MY, Kim SG, Lee HY, Lee JH, Lee YS, Kim JH, Jeong SW, Jang JY, Suk KT, Jung YK, An H, Yim HJ, Kim YS, Um SH; Korean Study Group of Portal Hypertension. Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study. Liver Int 2020;40:3083-92. [PMID: 32750739 DOI: 10.1111/liv.14631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
22 Kim JH, Kang SH, Lee M, Youn GS, Kim TS, Jun BG, Kim MY, Kim YD, Cheon GJ, Kim DJ, Baik SK, Choi DH, Suk KT. Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study. Cancers (Basel) 2020;12:E3347. [PMID: 33198216 DOI: 10.3390/cancers12113347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Yasuda K, Asou M, Asakawa T, Araki M. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report. J Med Case Rep 2020;14:192. [PMID: 33050943 DOI: 10.1186/s13256-020-02507-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Jeong J, Jung K, Seo KI, Yun BC, Han BH, Lee SU, Moon W. Propofol alone prevents worsening hepatic encephalopathy rather than midazolam alone or combined sedation after esophagogastroduodenoscopy in compensated or decompensated cirrhotic patients. Eur J Gastroenterol Hepatol 2020;32:1054-61. [PMID: 32433420 DOI: 10.1097/MEG.0000000000001755] [Reference Citation Analysis]
25 Yoon JS, Lee DH, Cho EJ, Song MK, Choi YH, Kim GB, Lee YB, Lee JH, Yu SJ, Kim H, Kim YJ, Yoon JH, Bae EJ. Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance. Cancers (Basel) 2020;12:E1805. [PMID: 32640555 DOI: 10.3390/cancers12071805] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
26 Park JG, Tak WY, Park SY, Kweon YO, Chung WJ, Jang BK, Bae SH, Lee HJ, Jang JY, Suk KT, Oh MJ, Heo J, Woo HY, Jang SY, Lee YR, Lee JS, Kim DY, Kim SH, Suh JI, Kim IH, Kang MK, Lee WK. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study. Nutrients 2020;12:E1429. [PMID: 32429077 DOI: 10.3390/nu12051429] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
27 Sohn W, Kim JH, Cho JY. Effect of acute kidney injury on long-term outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites-acute kidney injury criteria. J Gastroenterol Hepatol 2020;35:870-6. [PMID: 31816662 DOI: 10.1111/jgh.14871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Yoon JH, Kim HJ, Jun CH, Cho SB, Jung Y, Choi SK. Various Treatment Modalities in Hepatic Hydrothorax: What Is Safe and Effective? Yonsei Med J 2019;60:944-51. [PMID: 31538429 DOI: 10.3349/ymj.2019.60.10.944] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
29 Kim SW, Kim MA, Chang Y, Lee HY, Yoon JS, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Park KJ, Kim YJ. Prognosis of surgical hernia repair in cirrhotic patients with refractory ascites. Hernia 2020;24:481-8. [PMID: 31512088 DOI: 10.1007/s10029-019-02043-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Lee DH, Lee JY, Bae JS, Yi NJ, Lee KW, Suh KS, Kim H, Lee KB, Han JK. Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation. Radiology 2019;293:327-33. [PMID: 31502939 DOI: 10.1148/radiol.2019190064] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
31 Theodoridis X, Grammatikopoulou MG, Petalidou A, Kontonika S, Potamianos SP, Bogdanos DP. A Systematic Review of Medical Nutrition Therapy Guidelines for Liver Cirrhosis: Do We Agree? Nutrition in Clinical Practice 2020;35:98-107. [DOI: 10.1002/ncp.10393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
32 Yoo JJ, Kim SG, Kim YS, Lee B, Lee MH, Jeong SW, Jang JY, Lee SH, Kim HS, Kim YD, Cheon GJ. Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex. J Hepatol 2019;70:847-54. [PMID: 30630010 DOI: 10.1016/j.jhep.2018.12.030] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
33 Zhang J, Rössle M, Zhou X, Deng J, Liu L, Qi X. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence. Curr Med Res Opin 2019;35:859-68. [PMID: 30474439 DOI: 10.1080/03007995.2018.1552575] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
34 Park S, In Hwang S, Kim J, Hwang S, Kang S, Yang S, Kim J, Kang W, Kim KH, Han DW, Paik YH. The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis. Stem Cell Res Ther 2019;10:21. [PMID: 30635054 DOI: 10.1186/s13287-018-1127-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
35 Heo N. A Novel Biomarker for the Acute Kidney Injury in the Cirrhotic Patients. Korean J Gastroenterol 2019;74:191. [DOI: 10.4166/kjg.2019.74.4.191] [Reference Citation Analysis]
36 Kim JH, Choe WH, Kwon SY, Yoo BC. Prognosis of Spontaneous Bacterial Peritonitis in Hepatocellular Carcinoma Patients. J Korean Med Sci 2018;33:e335. [PMID: 30584413 DOI: 10.3346/jkms.2018.33.e335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
37 Seo YS. 2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines for Ascites and Related Complications: What Has Been Changed from the 2011 KASL Clinical Practice Guidelines? Korean J Gastroenterol 2018;72:179. [DOI: 10.4166/kjg.2018.72.4.179] [Reference Citation Analysis]